早孕期六重耐药恶性疟原虫感染降低新生儿出生体重
该研究随访从孕前或早孕期至分娩的孕妇,评估六重突变单倍型恶性疟原虫感染对间歇性预防治疗(IPTp)效果及出生结局的影响。提示六重突变单倍型感染可能影响磺胺多辛-乙胺嘧啶(SP)用于IPTp的效果并直接降低出生体重。
要点
- 早孕期感染六重突变单倍型恶性疟原虫与新生儿出生体重降低相关。
- 六重突变单倍型感染可能削弱SP用于IPTp的效果。
- 早孕期密切监测和针对性疟疾控制对改善出生结局至关重要。
核心结论
- 六重突变单倍型恶性疟原虫感染似乎影响SP用于IPTp的效果,并通过降低出生体重直接影响出生结局。
研究设计与样本
- 研究监测从孕前或早孕期随访至分娩的孕妇的出生结局,比较六重突变单倍型感染与孕期无疟疾及感染低耐药单倍型者的新生儿出生体重。
临床怎么用
- 早孕期应密切监测疟疾感染并实施针对性疟疾控制,以改善出生结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mutations in the Plasmodium falciparum genes Pfdhfr and Pfdhps, particularly the sextuple mutant haplotype threatens the antimalarial effectiveness of sulfadoxine-pyrimethamine (SP) as intermittent preventive treatment during pregnancy (IPTp). To explore the impact of sextuple mutant haplotype infections on outcome measures after provision of IPTp with SP, we monitored birth outcomes in women followed up from before conception or from the first trimester until delivery. Women infected with sextuple haplotypes, in the early second trimester specifically, delivered newborns with a lower birth weight compared with women who did not have malaria during pregnancy (difference, -267 g; 95% confidence interval, -454 to -59; P = .01) and women infected with less SP-resistant haplotypes (-461 g; -877 to -44; P = .03). Thus, sextuple haplotype infections seem to affect the effectiveness of SP for IPTp and directly affect birth outcome by lowering birth weight. Close monitoring and targeted malaria control during early pregnancy is therefore crucial to improving birth outcomes.
引用
- Hansson H, Minja DTR, Moeller SL, et al. Reduced Birth Weight Caused by Sextuple Drug-Resistant Plasmodium falciparum Infection in Early Second Trimester. J Infect Dis. 2021. PMID: 33684211. doi:10.1093/infdis/jiab117
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。